NCAM1 and metastatic melanoma: In primary melanoma cultures, increased expression of CD56 was identified in cells showing statistically significant higher capability to cross the in vitro blood-brain-barrier model81 and all cultures established from brain metastases of melanoma showed CD56 expression82, suggesting its role in invasion and its potential importance as a biomarker in metastatic melanoma.